Global Nitric Oxide Drugs & Therapeutics Market: Industry Analysis and Forecast (2020-2026) by Drug Type, Therapy, Application, End-Users, and Region

Global Nitric Oxide Drugs & Therapeutics Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of XX% during the forecast period.

Global Nitric Oxide Drugs & Therapeutics Market Overview:

Nitric oxide is a colourless, tasteless, and short-acting gas, which widens blood vessels in the lungs when inhaled. It is a key signalling molecule in the cardiovascular, immune and Central nervous systems. It is frequently used as the first line of treatment for oxygen-deprived premature babies.

Global Nitric Oxide Drugs & Therapeutics Market Dynamics:

The rising prevalence of neural disorders, respiratory disorders, and cardiovascular disorders are the major factors driving the market growth. The rise in the number of patients with chronic obstructive pulmonary disease (COPD) and acute respiratory diseases boost the growth of global nitric oxide drugs & the therapeutics market. Owing to its antiviral property and improved oxygenation nitric oxide is now being tested as an experimental treatment for COVID-19. Along with this, rising patient awareness, growing geriatric population, increasing research activities for developing novel therapeutic drugs are some factors that will help in augmenting the market growth. In addition to this, nitric oxide is also majorly used in the treatment of penile dysfunction. Nitric oxide played a central role in the development of the erectile dysfunction drug Viagra. The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.

Global Nitric Oxide Drugs & Therapeutics Market Segment Analysis:

The global Nitric Oxide Drugs & Therapeutics Market is segmented based on drug type, therapy, application, and end-users. Based on Therapy, the Inhalation therapy segment is expected to grow rapidly during the forecast period at a CAGR of 7.9%. The segment growth is anticipated due to the growing prevalence of respiratory disorders, breathing problems in neonates, and its current experimental use in the treatment of COVID-19 for the frontline workers contributes to the growth of the segment. On-going clinical trials, technological advancements, and new product launches are likely to create potential opportunities during the forecast period. Mallinckrodt has initiated a retrospective study for the use of inhaled nitric oxide in COVID-19 patients. Global Nitric Oxide Drugs & Therapeutics Market by Therapy To know about the Research Methodology :- Request Free Sample Report

Global Nitric Oxide Drugs & Therapeutics Market Regional Insights:

Global Nitric Oxide Drugs & Therapeutics Market by Regional

North America is expected to dominate the global market during the forecast period.

Most of the commercial developments of nitric oxide-based products are rapidly growing in the North American region, followed by Europe in the second place. Owing to the widespread application of nitric oxide in health & disease, nitric oxide-based therapies and products are developed and are approved in the USA and Europe, and they are expected to be the prominent players in the international markets in a very short time period. In addition to this, favorable government policies and increased funding for research activities help in propelling the market growth.

APAC is expected to be the fastest growing region.

Rising awareness among patients, increasing healthcare expenditure, changing lifestyle, the prevalence of respiratory and cardiovascular disorders are the key factors driving the market growth in the region. Well-developed medical infrastructure in the countries like India, China, Japan, and an increasing number of pharmaceutical companies in these countries also add up to the market growth. The report also helps in understanding Global Nitric Oxide Drugs & Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Nitric Oxide Drugs & Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nitric Oxide Drugs & Therapeutics Market make the report investor’s guide.

Global Nitric Oxide Drugs & Therapeutics Market scope: Inquire before buying

Global Nitric Oxide Drugs & Therapeutics Market by Scope

Global Nitric Oxide Drugs & Therapeutics Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Nitric Oxide Drugs & Therapeutics Market Key Players:

• Third Pole, Inc. • Novan, Inc. • Mallinckrodt • Pulmonox Group • AOBiome, LLC. • Novoteris, LLC. • Neogenis, Inc. • Bellerophone Therapeutics • BOC Healthcare • Dan Hammer Health Ltd. • EKU Elektronik • GeNO LLC • International Biomedical • Praxair Inc. • Vapotherm
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nitric Oxide Drugs & Therapeutics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Nitric Oxide Drugs & Therapeutics Market 3.4. Geographical Snapshot of the Nitric Oxide Drugs & Therapeutics Market, By Manufacturer share 4. Global Nitric Oxide Drugs & Therapeutics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Nitric Oxide Drugs & Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecast, 2019-2026 6.1. Global Nitric Oxide Drugs & Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 7.1.1. Inorganic drugs 7.1.2. Donating drugs 7.1.3. Hybrid drugs 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 7.2.1. Inhalation therapy 7.2.2. Gene therapy 7.2.3. Vascular therapy 7.2.4. Others 7.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.3.1. Inflammatory disorders 7.3.2. Cardiovascular diseases 7.3.3. Erectile dysfunction 7.3.4. Neuroprotection 7.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 7.4.1. Diagnostic laboratories 7.4.2. Pathology labs 7.4.3. Research lab 8. Global Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 9.1.1. Inorganic drugs 9.1.2. Donating drugs 9.1.3. Hybrid drugs 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 9.2.1. Inhalation therapy 9.2.2. Gene therapy 9.2.3. Vascular therapy 9.2.4. Others 9.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.3.1. Inflammatory disorders 9.3.2. Cardiovascular diseases 9.3.3. Erectile dysfunction 9.3.4. Neuroprotection 9.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 9.4.1. Diagnostic laboratories 9.4.2. Pathology labs 9.4.3. Research lab 10. North America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 11.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 12. Canada Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 13. Mexico Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 14. Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 15. Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 16.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 17. France Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 18. Germany Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 19. Italy Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 20. Spain Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 21. Sweden Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 22. CIS Countries Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 23. Rest of Europe Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 24. Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 25. Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 26.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 27. India Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 28. Japan Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 29. South Korea Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 30. Australia Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 31. ASEAN Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 32. Rest of Asia Pacific Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 33. Middle East Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 34. Middle East Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 35.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 36. GCC Countries Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 37. Egypt Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 38. Nigeria Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 39. Rest of ME&A Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 40. South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 41. South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 42.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 43. Argentina Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 44. Rest of South America Nitric Oxide Drugs & Therapeutics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Therapy, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Nitric Oxide Drugs & Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Third Pole, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Novan, Inc. 45.3.3. Mallinckrodt 45.3.4. Pulmonox Group 45.3.5. AOBiome, LLC. 45.3.6. Novoteris, LLC. 45.3.7. Neogenis, Inc. 45.3.8. Bellerophone Therapeutics 45.3.9. BOC Healthcare 45.3.10. Dan Hammer Health Ltd. 45.3.11. EKU Elektronik 45.3.12. GeNO LLC 45.3.13. International Biomedical 45.3.14. Praxair Inc. 45.3.15. Vapotherm 46. Primary Key Insights

About This Report

Report ID 91730
Category Healthcare
Published Date April 2021
Updated Date
Contact Us